RMD logo

ResMed (RMD) Shareholders Equity

Annual Shareholders Equity

$4.86 B
+$734.14 M+17.78%

30 June 2024

RMD Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$5.20 B
+$330.98 M+6.80%

30 September 2024

RMD Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RMD Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+17.8%+22.2%
3 y3 years+68.6%+71.7%
5 y5 years+134.7%+145.4%

RMD Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+68.6%at high+71.7%
5 y5 yearsat high+134.7%at high+145.4%
alltimeall timeat high>+9999.0%at high>+9999.0%

ResMed Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$5.20 B(+6.8%)
June 2024
$4.86 B(+17.8%)
$4.86 B(+5.1%)
Mar 2024
-
$4.63 B(+3.3%)
Dec 2023
-
$4.48 B(+5.4%)
Sept 2023
-
$4.25 B(+2.9%)
June 2023
$4.13 B(+22.9%)
$4.13 B(+5.0%)
Mar 2023
-
$3.93 B(+5.2%)
Dec 2022
-
$3.74 B(+8.9%)
Sept 2022
-
$3.43 B(+2.1%)
June 2022
$3.36 B(+16.5%)
$3.36 B(+2.5%)
Mar 2022
-
$3.28 B(+4.2%)
Dec 2021
-
$3.15 B(+4.0%)
Sept 2021
-
$3.03 B(+4.9%)
June 2021
$2.89 B(+15.6%)
$2.89 B(+6.5%)
Mar 2021
-
$2.71 B(-5.4%)
Dec 2020
-
$2.86 B(+6.9%)
Sept 2020
-
$2.68 B(+7.3%)
June 2020
$2.50 B(+20.5%)
$2.50 B(+10.7%)
Mar 2020
-
$2.26 B(-0.1%)
Dec 2019
-
$2.26 B(+6.7%)
Sept 2019
-
$2.12 B(+2.2%)
June 2019
$2.07 B(+0.6%)
$2.07 B(+2.5%)
Mar 2019
-
$2.02 B(+3.3%)
Dec 2018
-
$1.96 B(+2.9%)
Sept 2018
-
$1.90 B(-7.7%)
June 2018
$2.06 B(+5.0%)
$2.06 B(-0.4%)
Mar 2018
-
$2.07 B(+2.3%)
Dec 2017
-
$2.02 B(-1.5%)
Sept 2017
-
$2.05 B(+4.6%)
June 2017
$1.96 B(+15.7%)
$1.96 B(+5.7%)
Mar 2017
-
$1.85 B(+8.5%)
Dec 2016
-
$1.71 B(-3.5%)
Sept 2016
-
$1.77 B(+4.6%)
June 2016
$1.69 B(+6.8%)
$1.69 B(+1.3%)
Mar 2016
-
$1.67 B(+9.8%)
Dec 2015
-
$1.52 B(+4.3%)
Sept 2015
-
$1.46 B(-8.0%)
June 2015
$1.59 B(-9.7%)
$1.59 B(+3.3%)
Mar 2015
-
$1.54 B(-3.3%)
Dec 2014
-
$1.59 B(-3.9%)
Sept 2014
-
$1.65 B(-6.0%)
June 2014
$1.76 B(+9.2%)
$1.76 B(+4.0%)
Mar 2014
-
$1.69 B(+3.2%)
Dec 2013
-
$1.64 B(-3.2%)
Sept 2013
-
$1.69 B(+5.1%)
June 2013
$1.61 B(+0.2%)
$1.61 B(-8.9%)
Mar 2013
-
$1.77 B(+1.0%)
Dec 2012
-
$1.75 B(+3.1%)
Sept 2012
-
$1.70 B(+5.7%)
June 2012
$1.61 B(-7.1%)
$1.61 B(-0.1%)
Mar 2012
-
$1.61 B(+3.1%)
Dec 2011
-
$1.56 B(+0.8%)
Sept 2011
-
$1.55 B(-10.5%)
June 2011
$1.73 B(+34.4%)
$1.73 B(+4.0%)
Mar 2011
-
$1.66 B(+3.3%)
Dec 2010
-
$1.61 B(+9.1%)
Sept 2010
-
$1.48 B(+14.7%)
June 2010
$1.29 B
$1.29 B(-3.4%)
Mar 2010
-
$1.33 B(+5.9%)
DateAnnualQuarterly
Dec 2009
-
$1.26 B(+4.5%)
Sept 2009
-
$1.20 B(+7.9%)
June 2009
$1.12 B(+3.1%)
$1.12 B(+14.7%)
Mar 2009
-
$972.32 M(+0.9%)
Dec 2008
-
$963.57 M(-1.1%)
Sept 2008
-
$974.25 M(-9.9%)
June 2008
$1.08 B(+16.2%)
$1.08 B(+1.2%)
Mar 2008
-
$1.07 B(+5.4%)
Dec 2007
-
$1.01 B(+3.3%)
Sept 2007
-
$981.99 M(+5.5%)
June 2007
$931.22 M(+26.2%)
$931.22 M(+6.7%)
Mar 2007
-
$872.50 M(+2.5%)
Dec 2006
-
$850.82 M(+10.3%)
Sept 2006
-
$771.46 M(+4.5%)
June 2006
$738.15 M(+55.7%)
$738.15 M(+9.5%)
Mar 2006
-
$674.34 M(+28.4%)
Dec 2005
-
$525.10 M(+3.9%)
Sept 2005
-
$505.40 M(+6.6%)
June 2005
$474.06 M(+31.1%)
$474.06 M(+2.2%)
Mar 2005
-
$464.00 M(+8.6%)
Dec 2004
-
$427.40 M(+13.0%)
Sept 2004
-
$378.29 M(+4.6%)
June 2004
$361.50 M(+26.2%)
$361.50 M(+2.6%)
Mar 2004
-
$352.33 M(+5.9%)
Dec 2003
-
$332.67 M(+6.9%)
Sept 2003
-
$311.24 M(+8.7%)
June 2003
$286.43 M(+48.5%)
$286.43 M(+17.1%)
Mar 2003
-
$244.67 M(+11.8%)
Dec 2002
-
$218.82 M(+10.0%)
Sept 2002
-
$198.97 M(+3.1%)
June 2002
$192.93 M(+92.2%)
$192.93 M(+36.1%)
Mar 2002
-
$141.72 M(+10.7%)
Dec 2001
-
$128.06 M(+9.8%)
Sept 2001
-
$116.63 M(+16.2%)
June 2001
$100.37 M(+6.8%)
$100.37 M(+15.0%)
Mar 2001
-
$87.27 M(-19.1%)
Dec 2000
-
$107.84 M(+12.0%)
Sept 2000
-
$96.29 M(+2.5%)
June 2000
$93.97 M(+31.2%)
$93.97 M(+7.8%)
Mar 2000
-
$87.21 M(+4.3%)
Dec 1999
-
$83.60 M(+9.3%)
Sept 1999
-
$76.50 M(+6.8%)
June 1999
$71.60 M(+40.9%)
$71.60 M(+10.8%)
Mar 1999
-
$64.60 M(+8.2%)
Dec 1998
-
$59.70 M(+9.9%)
Sept 1998
-
$54.30 M(+6.9%)
June 1998
$50.80 M(+13.9%)
$50.80 M(+3.7%)
Mar 1998
-
$49.00 M(+7.9%)
Dec 1997
-
$45.40 M(-2.8%)
Sept 1997
-
$46.70 M(+4.7%)
June 1997
$44.60 M(+14.4%)
$44.60 M(+2.3%)
Mar 1997
-
$43.60 M(+2.3%)
Dec 1996
-
$42.60 M(+3.9%)
Sept 1996
-
$41.00 M(+5.1%)
June 1996
$39.00 M(+34.9%)
$39.00 M(+4.0%)
Mar 1996
-
$37.50 M(+29.8%)
June 1995
$28.90 M(+416.1%)
$28.90 M(+416.1%)
June 1994
$5.60 M(+93.1%)
$5.60 M(+93.1%)
June 1993
$2.90 M
$2.90 M

FAQ

  • What is ResMed annual stockholders equity?
  • What is the all time high annual shareholders equity for ResMed?
  • What is ResMed annual shareholders equity year-on-year change?
  • What is ResMed quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for ResMed?
  • What is ResMed quarterly shareholders equity year-on-year change?

What is ResMed annual stockholders equity?

The current annual shareholders equity of RMD is $4.86 B

What is the all time high annual shareholders equity for ResMed?

ResMed all-time high annual stockholders equity is $4.86 B

What is ResMed annual shareholders equity year-on-year change?

Over the past year, RMD annual stockholders equity has changed by +$734.14 M (+17.78%)

What is ResMed quarterly stockholders equity?

The current quarterly shareholders equity of RMD is $5.20 B

What is the all time high quarterly shareholders equity for ResMed?

ResMed all-time high quarterly stockholders equity is $5.20 B

What is ResMed quarterly shareholders equity year-on-year change?

Over the past year, RMD quarterly stockholders equity has changed by +$944.65 M (+22.23%)